Generation Bio Ownership | Who Owns Generation Bio?
Generation Bio Ownership Summary
Generation Bio is owned by 82.76% institutional investors, 14.51% insiders, and 2.72% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 14.32% of GBIO shares. T. Rowe Price New Horizons is the top mutual fund, with 8.00% of its assets in Generation Bio shares.
GBIO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Generation Bio | 82.76% | 14.51% | 2.72% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Price t rowe associates inc /md/ | 9.51M | 14.32% | $26.83M |
Atlas venture life science advisors | 8.28M | 12.46% | $23.35M |
Fmr | 5.30M | 7.98% | $14.96M |
Bellevue group | 3.92M | 5.90% | $11.05M |
Blackrock | 3.29M | 4.96% | $9.29M |
Bank of america corp /de/ | 2.98M | 4.49% | $8.41M |
Artal group | 2.83M | 4.26% | $7.98M |
Vanguard group | 2.59M | 3.90% | $7.30M |
Ecor1 capital | 2.05M | 3.08% | $5.77M |
Goldman sachs group | 1.28M | 1.92% | $3.60M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Atlas venture life science advisors | 8.28M | 2.46% | $23.35M |
Artal group | 2.83M | 0.20% | $7.98M |
Bellevue group | 3.92M | 0.18% | $11.05M |
Ecor1 capital | 2.05M | 0.18% | $5.77M |
Pfm health sciences, lp | 787.91K | 0.11% | $2.22M |
Palo alto investors lp | 150.47K | 0.05% | $424.34K |
Yiheng capital management | 191.53K | 0.04% | $540.12K |
Baker bros. advisors lp | 1.21M | 0.04% | $3.40M |
Xtx topco | 132.72K | 0.03% | $374.26K |
Cornercap investment counsel | 57.42K | 0.03% | $161.94K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | 1.21M | 0.04% | 835.74K |
Price t rowe associates inc /md/ | 9.51M | 0.00% | 635.26K |
Jacobs levy equity management | 301.05K | 0.00% | 268.70K |
Blackrock | 3.29M | 0.00% | 245.40K |
Palo alto investors lp | 150.47K | 0.05% | 150.47K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pfm health sciences, lp | 787.91K | 0.11% | -834.57K |
Deutsche bank ag\ | 558.00K | 0.00% | -693.57K |
Millennium management | 97.95K | 0.00% | -124.80K |
Jpmorgan chase | 173.69K | - | -94.38K |
Two sigma investments, lp | 229.42K | 0.00% | -84.73K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Palo alto investors lp | 150.47K | 0.05% | 150.47K | $424.34K |
Wellington management group llp | 119.36K | 0.00% | 119.36K | $336.58K |
Corebridge financial | 26.62K | 0.00% | 26.62K | $75.07K |
Mirae asset global etfs | 22.78K | 0.00% | 22.78K | $64.23K |
Ameriprise financial | 17.77K | - | 17.77K | $50.12K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -9.00 |
Point72 (difc) | -218.00 |
Metropolitan life insurance co/ny | -2.51K |
Sherbrooke park advisers | -11.16K |
Sg americas securities | -16.63K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 75 | -3.85% | 55,236,045 | -0.45% | 82 | 1.19% | 26 | -36.59% | 27 | 17.39% |
Jun 30, 2024 | 77 | - | 55,483,273 | 0.97% | 83 | 1.21% | 41 | 10.81% | 23 | -14.81% |
Mar 31, 2024 | 77 | - | 54,950,287 | 4.52% | 83 | 1.31% | 37 | -27.45% | 27 | 80.00% |
Dec 31, 2023 | 77 | -2.53% | 52,571,581 | -8.10% | 79 | 1.05% | 51 | 82.14% | 15 | -42.31% |
Sep 30, 2023 | 79 | -4.82% | 57,207,526 | -0.16% | 87 | 0.96% | 28 | -28.21% | 26 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
T. Rowe Price New Horizons | 5.34M | 8.00% | -16.83K |
US Small-Cap Growth II Equity Comp | 5.34M | 8.00% | -18.99K |
BB Biotech AG Ord | 3.92M | 5.87% | - |
Fidelity Growth Compy Commingled Pl S | 1.95M | 2.93% | 12.69K |
Fidelity Growth Compy Commingled Pl O | 1.94M | 2.91% | - |
Fidelity Growth Company Fund | 1.82M | 2.72% | -3.86K |
T. Rowe Price Health Sciences | 1.76M | 2.64% | -35.10K |
Vanguard Total Stock Mkt Idx Inv | 1.56M | 2.33% | - |
iShares Russell 2000 ETF | 1.25M | 1.87% | -2.81K |
T. Rowe Price New Horizons Tr-Z | 1.04M | 1.55% | 18.99K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 01, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $18.41K |
Jan 02, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $3.96K |
Jan 02, 2024 | Samayoa Phillip | CHIEF STRATEGY OFFICER | Sell | $3.96K |
Dec 08, 2023 | Appelhans Dannielle | - | Buy | $13.18K |
Dec 08, 2023 | Appelhans Dannielle | - | Buy | $1.16K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | 2 |
2023 Q4 | 7 | - |
GBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools